Common deleted genes in the 5q− syndrome: thrombocytopenia and reduced erythroid colony formation in SPARC null mice (original) (raw)

• Catenacci DV, Schiller GJ . Myelodysplasic syndromes: a comprehensive review. Blood Rev 2005; 19: 301–319.
  Article CAS Google Scholar
• Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 1986; 4: 325–345.
  Article CAS Google Scholar
• Solé F, Espinet B, Sanz GF, Cervera J, Calasanz MJ, Luño E et al. Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Espanol de Citogenetica Hematologica. Br J Haematol 2000; 108: 346–356.
  Article Google Scholar
• Heim S, Mitelman F . Chromosome abnormalities in the myelodysplastic syndromes. Clin Haematol 1986; 4: 1003–1021.
  Google Scholar
• Van den Berghe H, Cassiman JJ, David G, Fryns JP, Michaux JL, Sokal G . Distinct haematological disorder with deletion of long arm of no. 5 chromosome. Nature 1974; 251: 437–438.
  Article CAS Google Scholar
• Boultwood J, Lewis S, Wainscoat JS . The 5q− syndrome. Blood 1994; 84: 3253–3260.
  CAS Google Scholar
• Nilsson L, Astrand-Grundstrom I, Anderson K, Arvidsson I, Hokland P, Bryder D et al. Involvement and functional impairment of the CD34(+)CD38(−)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8. Blood 2002; 100: 259–267.
  CAS Google Scholar
• Boultwood J, Fidler C, Strickson AJ, Watkins F, Gama S, Kearney L et al. Narrowing and genomic annotation of the commonly deleted region of the 5q−syndrome. Blood 2002; 99: 4638–4641.
  Article CAS Google Scholar
• Horrigan SK, Westbrook CA, Kim AH, Banerjee M, Stock W, Larson RA . Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval. Blood 1996; 88: 2665–2670.
  CAS Google Scholar
• Zhao N, Stoffel A, Wang PW, Eisenbart JD, Espinosa R, Larson RA et al. Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1–1.5 Mb and preparation of a PAC-based physical map. Proc Natl Acad Sci USA 1997; 94: 6948–6953.
  Article CAS Google Scholar
• Bradshaw AD, Sage EH . SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 2001; 107: 1049–1054.
  Article CAS Google Scholar
• Framson PE, Sage EH . SPARC and tumor growth: where the seed meets the soil? J Cell Biochem 2004; 92: 679–690.
  Article CAS Google Scholar
• Yan Q, Clark JI, Wight TN, Sage EH . Alterations in the lens capsule contribute to cataractogenesis in SPARC-null mice. J Cell Sci 2002; 115: 2747–2756.
  CAS Google Scholar
• Bradshaw AD, Graves DC, Motamed K, Sage EH . SPARC-null mice exhibit increased adiposity without significant differences in overall body weight. Proc Natl Acad Sci USA 2003; 100: 6045–6050.
  Article CAS Google Scholar
• Clezardin P, Malaval L, Ehrensperger AS, Delmas PD, Dechavanne M, McGregor JL . Complex formation of human thrombospondin with osteonectin. Eur J Biochem 1988; 175: 275–284.
  Article CAS Google Scholar
• Clezardin P, Malaval L, Ehrensperger AS, Delmas PD, Dechavanne M, McGregor JL . Osteonectin is an _α_-granule component involved with thrombospondin in platelet aggregation. J Bone Miner Res 1991; 6: 1059–1070.
  Article CAS Google Scholar
• Koblinski JE, Kaplan-Singer BR, VanOsdol SJ, Wu M, Engbring JA, Wang S et al. Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis. Cancer Res 2005; 65: 7370–7377.
  Article CAS Google Scholar
• Suzuki M, Hao C, Takahashi T, Shigematsu H, Shivapurkar N, Sathyanarayana UG et al. Aberrant methylation of SPARC in human lung cancers. Br J Cancer 2005; 92: 942–948.
  Article CAS Google Scholar
• Sato N, Fukushima N, Maehara N, Matsubayashi H, Koopmann J, Su GH et al. SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor–stromal interactions. Oncogene 2003; 22: 5021–5030.
  Article CAS Google Scholar
• Koeffler HP, Golde DW . Human myeloid leukemia cell lines: a review. Blood 1980; 56: 344–350.
  CAS Google Scholar
• Norose K, Clark JI, Syed NA, Basu A, Heber-Katz E, Sage EH et al. SPARC deficiency leads to early onset cataractogenesis. Invest Ophthalmol Vis Sci 1998; 39: 2674–2680.
  CAS Google Scholar
• Irvine K, Stirling R, Hume D, Kennedy D . Rasputin, more promiscuous than ever: a review of G3BP. Int J Dev Biol 2004; 48: 1065–1077.
  Article CAS Google Scholar
• Harris ED . Basic and clinical aspects of copper. Crit Rev Clin Lab Sci 2003; 40: 547–586.
  Article CAS Google Scholar
• Roussel MF, Sherr CJ . Oncogenic potential of the c-FMS proto-oncogene (CSF-1 receptor). Cell Cycle 2003; 2: 5–6.
  Article CAS Google Scholar
• Ebert BL, Lee MM, Pretz JL, Subramanian A, Mak R, Golub TR et al. An RNA interference model of RPS19 deficiency in Diamond–Blackfan anemia recapitulates defective hematopoiesis and rescue by dexamethasone: identification of dexamethasone-responsive genes by microarray. Blood 2005; 105: 4620–4626.
  Article CAS Google Scholar
• Yiu GK, Chan WY, Ng SW, Chan PS, Cheung KK, Berkowitz RS et al. SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells. Am J Pathol 2001; 159: 609–622.
  Article CAS Google Scholar
• Dhanesuan N, Sharp JA, Blick T, Price JT, Thompson EW . Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition. Breast Cancer Res Treat 2002; 75: 73–85.
  Article CAS Google Scholar
• Bradshaw AD, Francki A, Motamed K, Howe C, Sage EH . Primary mesenchymal cells isolated from SPARC-null mice exhibit altered morphology and rates of proliferation. Mol Biol Cell 1999; 10: 1569–1579.
  Article CAS Google Scholar
• Francki A, Motamed K, McClure TD, Kaya M, Murri C, Blake DJ et al. SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling. J Cell Biochem 2003; 88: 802–811.
  Article CAS Google Scholar
• Schultz C, Lemke N, Ge S, Golembieski WA, Rempel SA . Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo. Cancer Res 2002; 62: 6270–6277.
  CAS Google Scholar
• Gregory CJ, Eaves AC . Three stages of erythropoietic progenitor cell differentiation distinguished by a number of physical and biologic properties. Blood 1978; 51: 527–537.
  CAS Google Scholar
• Chui DH, Liao SK, Walker K . Fetal erythropoiesis in steel mutant mice. III. Defect in differentiation from BFU-E to CFU-E during early development. Blood 1978; 51: 539–547.
  CAS Google Scholar